Majority of Patients with C Diff Willing to Use Rectally Administered Treatment
Survey results showed patients with a history of live biotherapeutic product therapy preferred rectally administered treatment while patients who had not received live biotherapeutic product therapy would be willing to consider it.
Source: hcplive.com